Furihata T - Search Results

1

Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer.

Woess K, Sun Y, Morio H, Stierschneider A, Kaufmann A, Hainzl S, Trattner L, Kocher T, Tockner B, Leb-Reichl V, Steiner M, Brachtl G, South AP, Bauer JW, Reichelt J, Furihata T, Wally V, Koller U, Piñón Hofbauer J, Guttmann-Gruber C. Woess K, et al. Among authors: furihata t. Int J Mol Sci. 2022 Jan 5;23(1):575. doi: 10.3390/ijms23010575. Int J Mol Sci. 2022. PMID: 35008999 Free PMC article.

2

Cancer-type Organic Anion Transporting Polypeptide 1B3: Current Knowledge of the Gene Structure, Expression Profile, Functional Implications and Future Perspectives.

Furihata T, Sun Y, Chiba K. Furihata T, et al. Curr Drug Metab. 2015;16(6):474-85. doi: 10.2174/1389200216666150812142715. Curr Drug Metab. 2015. PMID: 26264344 Review.

3

Extracellular Vesicles as Biomarkers for the Detection of a Tumor Marker Gene in Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.

Sun Y, Woess K, Kienzl M, Leb-Reichl VM, Feinle A, Wimmer M, Zauner R, Wally V, Luetz-Meindl U, Mellerio JE, Fuentes I, South AP, Bauer JW, Reichelt J, Furihata T, Guttmann-Gruber C, Piñón Hofbauer J. Sun Y, et al. Among authors: furihata t. J Invest Dermatol. 2018 May;138(5):1197-1200. doi: 10.1016/j.jid.2017.11.022. Epub 2017 Dec 2. J Invest Dermatol. 2018. PMID: 29203361 Free article. No abstract available.

4

Cancer-Type OATP1B3 mRNA in Extracellular Vesicles as a Promising Candidate for a Serum-Based Colorectal Cancer Biomarker.

Morio H, Sun Y, Harada M, Ide H, Shimozato O, Zhou X, Higashi K, Yuki R, Yamaguchi N, Hofbauer JP, Guttmann-Gruber C, Anzai N, Akita H, Chiba K, Furihata T. Morio H, et al. Among authors: furihata t. Biol Pharm Bull. 2018;41(3):445-449. doi: 10.1248/bpb.b17-00743. Biol Pharm Bull. 2018. PMID: 29491222 Free article.

5

Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology.

Sun Y, Piñón Hofbauer J, Harada M, Wöss K, Koller U, Morio H, Stierschneider A, Kitamura K, Hashimoto M, Chiba K, Akita H, Anzai N, Reichelt J, Bauer JW, Guttmann-Gruber C, Furihata T. Sun Y, et al. Among authors: furihata t. Cancer Lett. 2018 Oct 1;433:107-116. doi: 10.1016/j.canlet.2018.06.032. Epub 2018 Jun 27. Cancer Lett. 2018. PMID: 29960051

6

Differentiated HASTR/ci35 cells: A promising in vitro human astrocyte model for facilitating CNS drug development studies.

Kitamura K, Ito R, Umehara K, Morio H, Saito K, Suzuki S, Hashimoto M, Saito Y, Anzai N, Akita H, Chiba K, Furihata T. Kitamura K, et al. Among authors: furihata t. J Pharmacol Sci. 2018 Aug;137(4):350-358. doi: 10.1016/j.jphs.2018.06.013. Epub 2018 Aug 9. J Pharmacol Sci. 2018. PMID: 30150146 Free article.

7

Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203.

Muto Y, Furihata T, Kaneko M, Higuchi K, Okunushi K, Morio H, Reien Y, Uesato M, Matsubara H, Anzai N. Muto Y, et al. Among authors: furihata t. Anticancer Res. 2019 Jan;39(1):159-165. doi: 10.21873/anticanres.13092. Anticancer Res. 2019. PMID: 30591453

8

Development, Characterization and Potential Applications of a Multicellular Spheroidal Human Blood-Brain Barrier Model Integrating Three Conditionally Immortalized Cell Lines.

Kitamura K, Umehara K, Ito R, Yamaura Y, Komori T, Morio H, Akita H, Furihata T. Kitamura K, et al. Among authors: furihata t. Biol Pharm Bull. 2021 Jul 1;44(7):984-991. doi: 10.1248/bpb.b21-00218. Epub 2021 Apr 24. Biol Pharm Bull. 2021. PMID: 33896887 Free article.

9

In Vitro-In Vivo Correlation of Blood-Brain Barrier Permeability of Drugs: A Feasibility Study Towards Development of Prediction Methods for Brain Drug Concentration in Humans.

Ito R, Morio H, Baba T, Sakaguchi Y, Wakayama N, Isogai R, Yamaura Y, Komori T, Furihata T. Ito R, et al. Among authors: furihata t. Pharm Res. 2022 Jul;39(7):1575-1586. doi: 10.1007/s11095-022-03189-y. Epub 2022 Mar 14. Pharm Res. 2022. PMID: 35288803

10

Human Immortalized Cell-Based Blood-Brain Barrier Spheroid Models Offer an Evaluation Tool for the Brain Penetration Properties of Macromolecules.

Kitamura K, Okamoto A, Morio H, Isogai R, Ito R, Yamaura Y, Izumi S, Komori T, Ito S, Ohtsuki S, Akita H, Furihata T. Kitamura K, et al. Among authors: furihata t. Mol Pharm. 2022 Aug 1;19(8):2754-2764. doi: 10.1021/acs.molpharmaceut.2c00120. Epub 2022 Jun 29. Mol Pharm. 2022. PMID: 35766901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters